Scientists in Switzerland have cracked open a century-old viral mystery by decoding the genome of the 1918 influenza virus ...

The H5N1 bird flu virus has historically extracted a heavy toll when it infects humans, with nearly half of confirmed cases ...

Scientists in Switzerland have cracked open a century-old viral mystery by decoding the genome of the 1918 influenza virus.

Scientists have decoded the Swiss genome of the 1918 flu virus from a century-old specimen, revealing early adaptations for ...

Novavax, Inc. (Nasdaq: NVAX) today announced preclinical data demonstrating that Novavax's H5N1 avian pandemic influenza ...

Novavax's H5N1 avian pandemic influenza vaccine candidate demonstrates immunogenicity in preclinical study: Gaithersburg, Maryland Friday, July 25, 2025, 15:00 Hrs [IST] Novavax, ...

The fatality rate for H5N1 highly pathogenic avian influenza in humans has historically been high, with more than half of ...

Novavax reports strong immune responses from H5N1 avian flu vaccine candidate, showing promise in single and two-dose ...

Once used for tracking COVID-19 cases, the tracker has become a resource for virus trends in general, including measles.

Scientists have successfully decoded the genome of the 1918 influenza virus from a preserved Swiss patient sample. The research reveals that the virus already possessed key adaptations for human hosts ...

Ensuring the seasonal flu vaccine is ready, safe and effective involves months of international planning, testing and ...

Microbix & API Presenting H5N1 Pandemic Preparedness Results. MISSISSAUGA, Ontario, July 24, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®) ...